These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7032829)

  • 1. The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension.
    De Crée J; Leempoels J; Geukens H; De Cock W; Verhaegen H
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():473s-476s. PubMed ID: 7032829
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketanserin in essential hypertension: a double-blind, placebo-controlled study.
    Cameron HA; Ramsay LE
    Postgrad Med J; 1985 Jul; 61(717):583-6. PubMed ID: 3161013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of ketanserin and metoprolol in essential hypertension.
    Seedat YK; Parag KB
    S Afr Med J; 1985 Oct; 68(8):555-8. PubMed ID: 2931840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with ketanserin and ritanserin in hypertensive patients.
    Hedner T; Persson B
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
    J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist.
    Weiner CP; Socol ML; Vaisrub N
    Am J Obstet Gynecol; 1984 Jul; 149(5):496-500. PubMed ID: 6377898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive properties of ketanserin in combination with beta-adrenergic blocking agents.
    Hedner T; Persson B
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S161-3. PubMed ID: 2412042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
    Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
    Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ketanserin on blood pressure and biochemical parameters in treated patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    Clin Exp Hypertens A; 1984; 6(6):1107-17. PubMed ID: 6146414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketanserin in the treatment of hypertension following coronary artery bypass surgery. A preliminary study.
    Diedericks BJ; Roelofse JA; De Wet JI
    S Afr Med J; 1983 Oct; 64(15):569-71. PubMed ID: 6604947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
    Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute antihypertensive effect of ketanserin increases with age.
    De Crée J; Hoing M; De Ryck M; Symoens J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S126-7. PubMed ID: 2412033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antihypertensive effects of a pure and selective serotonin-receptor blocking agent (R 41 468) in elderly patients.
    De Cree J; Leempoels J; De Cock W; Geukens H; Verhaegen H
    Angiology; 1981 Feb; 32(2):137-44. PubMed ID: 7011110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketanserin (S2-receptor blocking agents), hypertension and chronic alcoholism.
    De Lorenzo A; Ceccanti M; Romeo M; Pisculli M; Di Giovanni MG; Lais A; Assogna G; Valgiusti FC
    Int J Clin Pharmacol Res; 1986; 6(1):77-9. PubMed ID: 2937747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketanserin in essential hypertension: effects during rest and exercise.
    Persson B; Hedner T; Berglund G
    Eur J Clin Pharmacol; 1983; 25(3):307-12. PubMed ID: 6628517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic 5-HT2-receptor blockade by ritanserin does not reduce blood pressure in patients with essential hypertension.
    Hedner T; Pettersson A; Persson B
    Acta Med Scand; 1987; 222(4):307-10. PubMed ID: 2892349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ketanserin and pindolol in hypertension.
    Gordin A; Saraste K; Turanlahti M; Sundberg S
    J Hypertens Suppl; 1986 Apr; 4(1):S61-2. PubMed ID: 2939214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic effect of ketanserin in mild to moderate essential hypertension.
    Woittiez AJ; Wenting GJ; van den Meiracker AH; Ritsema van Eck HJ; Man in't Veld AJ; Zantvoort FA; Schalekamp MA
    Hypertension; 1986 Feb; 8(2):167-73. PubMed ID: 2935497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single doses of ketanserin and placebo in chronic stable angina.
    Cameron HA; Cameron CM; Ramsay LE
    Br J Clin Pharmacol; 1986 Jul; 22(1):114-6. PubMed ID: 2874825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ketanserin on blood pressure and biochemical parameters in patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S164-7. PubMed ID: 2412043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.